APA (7th ed.) Citation

Diaz, L. A., Morris, S., Dave, S., Kim, S. M., Sarik, W., Richards, L., . . . Loomba, R. (2025). Clinical Trial to Assess the Safety and Tolerability of Anti‐IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol‐Associated Liver Disease. Alimentary Pharmacology & Therapeutics, 61(7), 1140. https://doi.org/10.1111/apt.70026

Chicago Style (17th ed.) Citation

Diaz, Luis Antonio, et al. "Clinical Trial to Assess the Safety and Tolerability of Anti‐IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol‐Associated Liver Disease." Alimentary Pharmacology & Therapeutics 61, no. 7 (2025): 1140. https://doi.org/10.1111/apt.70026.

MLA (9th ed.) Citation

Diaz, Luis Antonio, et al. "Clinical Trial to Assess the Safety and Tolerability of Anti‐IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol‐Associated Liver Disease." Alimentary Pharmacology & Therapeutics, vol. 61, no. 7, 2025, p. 1140, https://doi.org/10.1111/apt.70026.